DCGI gives go-ahead for study on mixing Covishield and Covaxin

A study on mixing Covishield and Covaxin, the two main vaccines used in India’s COVID-19 vaccination programme, has been given the go-ahead by the Drugs Controller General Of India (DCGI).

This study and its clinical trials will be conducted by Vellore’s Christian Medical College.

“Permission has been granted for a research study by CMC Vellore (Tamil Nadu) on mixing of vaccines doses,” Dr VK Paul, NITI Aayog Member (Health), said during a press briefing on Tuesday.

A Subject Expert Committee of the Central Drugs Standard Control Organisation (CDSCO) had recommended conducting the study on July 29.

This study will be different from the one by the Indian Council of Medical Research (ICMR), which said mixing the two Covid vaccines elicited better safety and immunogenicity results.

The mixing of doses had raised considerable anxiety.